GnRH Replacement Therapy In Adults With Down Syndrome: Study Findings & New Perspectives
Wednesday, February 08, 2023, 12:00 PM EDT
Category: Webinars
Research recently published in the journal Science raises the possibility that a currently-approved drug may offer an effective boost in cognition and smell when administered to people with Down syndrome. The new research is based on a theory that as their brains develop, people with Down syndrome tend to lose special neurons that make an important protein, called gonadotropin-releasing hormone or GnRH.
Dr. Vincent Prevot and Dr. Nelly Pittleoud will present the findings of their pilot study on GnRH replacement therapy in 7 adults with DS as a means to boost cognition and smell in people with Down syndrome, as well as the protocol for the new double-bind, placebo-controlled study that will be launched in spring 2023. Following the presentations there will be Q&A sessions with the researchers.
Register in advance for this webinar here. (It’s free!)
Contact: Kate O’Neill; [email protected]
|